65,437 trials
Diabetes Mellitus, Type 2
Primary: Number of Participants With Any Adverse Event (AE), Serious Adverse Event (SAE), AE Related to Study Medication, AE Leading to Discontinuation and Fatal AE of Death…
Sleep Disordered Breathing · Nocturnal Oxygen Desaturation · Upper Airway Edema
Primary: SpO2 < 90% — 0.4; 0.0; 0.1; 0.0 minutes
Dementia
Primary: World Health Organization Brief Quality of Life Scale — 2.5; 2 units on a scale
Non-Hodgkin Lymphoma · Chronic Lymphocytic Leukemia
Primary: Maximum Tolerated Dose (MTD) — NA; NA; NA; NA mcg/Kg
Chronic Low Back Pain
Primary: Percentage of Patients With Available Step Count Data at Baseline. — 93.3; 71.4 percentage of patients with step data
Multiple Myeloma
Primary: The Best Overall Response Rate (ORR) — 11 Participants
Intra-abdominal Infection
Primary: Clinical Response at the Test-of-Cure (TOC) Assessment Within the Clinically Evaluable (CE) Population — 89.9; 96.6; 10.1; 3.4 percentage of participants — p=0.0008
Smoking Cessation
Primary: Number of Participants With a Smoking Quit Attempt in the Prior Six Weeks — 10; 1 Participants
Osteoarthritis · Arthroplasty
Primary: Pain Score at 3 Hours — 4.0; 2.9 units on a scale — p=0.036
Dermatitis, Contact
Primary: Analysis of Bioequivalence: Concordance — 76; 98.0 percentage of agreement
Cigarette Smoking · Marijuana Abuse
Primary: Number of Participants Who Self-report Prolonged Abstinence From Smoking — 0 Participants
Breast Neoplasms
Primary: Number of Patients With Less Than Two Lymph Nodes Detected — 22; 20 Participants
Migraine
Primary: Pain Score 1-hour — -59; -30 percent change — p=<0.0001
Pressure Ulcer
Primary: Count of Participants With Pressure Ulcer According to the National Pressure Ulcer Advisory Panel (NPUAP) Criteria for Pressure Ulcers — 5; 15 Participants — p=.012
Dental Adhesive
Primary: Number of Participants With Clinical Success — 28 Participants